Werner Müller-Esterl Selected Research

des-Arg(10)- kallidin

1/2012

Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Werner Müller-Esterl Research Topics

Disease

8	Inflammation (Inflammations) 01/2019 - 08/2002
5	Infections 12/2010 - 01/2003
4	Edema (Dropsy) 02/2011 - 01/2003
3	Pain (Aches) 09/2005 - 10/2003
2	Neoplasms (Cancer) 01/2012 - 03/2002
2	Vascular Diseases (Vascular Disease) 07/2009 - 09/2006
2	Hypersensitivity (Allergy) 10/2003 - 03/2003
1	Glioma (Gliomas) 01/2012
1	Brain Neoplasms (Brain Tumor) 01/2012
1	Hereditary Angioedemas 02/2011
1	Hemolysis 12/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2010
1	Brain Edema (Cerebral Edema) 01/2010
1	Contusions 01/2010
1	Wounds and Injuries (Trauma) 01/2010
1	Vasculitis (Vasculitides) 06/2009
1	Portal Hypertension 06/2007
1	Fibrosis (Cirrhosis) 06/2007
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 06/2007
1	Alcoholic Hepatitis 06/2007
1	Diabetes Mellitus 09/2006
1	Pre-Eclampsia (Preeclampsia) 06/2006
1	Placenta Accreta 06/2006
1	Visceral Leishmaniasis (Kala Azar) 01/2006
1	Angioedema 12/2005
1	Chronic Pain 10/2003
1	Thrombosis (Thrombus) 06/2003
1	Flaujeac factor deficiency 06/2003
1	Hypertension (High Blood Pressure) 03/2003
1	Heart Diseases (Heart Disease) 01/2003
1	Tics (Tic) 03/2002

Drug/Important Bio-Agent (IBA)

9	KininsIBA 01/2012 - 08/2002
7	BradykininIBA 01/2019 - 03/2002
3	Peptides (Polypeptides)IBA 01/2012 - 03/2005
3	Proteins (Proteins, Gene)FDA Link 12/2010 - 10/2003
3	2,5-dichloro-4-bromophenol (B 2)IBA 01/2010 - 03/2003
2	Heme (Haem)IBA 07/2009 - 09/2006
2	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 06/2009 - 06/2003
2	EnzymesIBA 06/2007 - 09/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 06/2007 - 10/2003
2	Kininogens (Kininogen)IBA 11/2006 - 06/2003
2	Bradykinin B2 ReceptorIBA 11/2006 - 06/2006
2	icatibantIBA 01/2006 - 03/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2005 - 01/2003
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2005 - 01/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2003 - 03/2002
1	Chemotactic FactorsIBA 01/2019
1	des-Arg(10)- kallidinIBA 01/2012
1	Carboplatin (JM8)FDA LinkGeneric 01/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2012
1	Sar-Lys-Phe(8)-desArg(9)- bradykininIBA 01/2012
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 02/2011
1	Heparin (Liquaemin)FDA LinkGeneric 02/2011
1	Factor XII (Hageman Factor)IBA 02/2011
1	AllergensIBA 02/2011
1	CystatinsIBA 12/2010
1	Complement System Proteins (Complement)IBA 12/2010
1	ClusterinIBA 12/2010
1	Blood Proteins (Serum Proteins)IBA 12/2010
1	histidine-rich proteinsIBA 12/2010
1	salicylhydroxamic acid (SHAM)IBA 01/2010
1	Soluble Guanylyl CyclaseIBA 07/2009
1	Myeloblastin (Proteinase 3)IBA 06/2009
1	Plasma KallikreinIBA 06/2009
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	Caveolin 1IBA 06/2007
1	Messenger RNA (mRNA)IBA 06/2007
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2006
1	MucinsIBA 11/2006
1	Peptide Hydrolases (Proteases)FDA Link 11/2006
1	Interleukin-12 (IL 12)IBA 11/2006
1	cruzipainIBA 11/2006
1	Kallikreins (Kallikrein)IBA 06/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2006
1	Cysteine Proteases (Cysteine Protease)IBA 01/2006
1	Metalloproteases (Metalloproteinases)IBA 12/2005
1	Captopril (Capoten)FDA LinkGeneric 01/2003
1	LipopolysaccharidesIBA 01/2003
1	Bradykinin Receptors (Bradykinin Receptor)IBA 03/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2012
1	Aftercare (After-Treatment) 01/2003